semaglutide franklin tn GLP-1 Injections in Franklin, Hormone Therapy in Franklin Tennessee

As with any treatment, its important to discuss the potential benefits and risks with your doctor

SURMOUNT-1: Tirzepatide for Obesity The SURMOUNT-1 trial (NEJM, 2022) studied tirzepatide weight loss in 2,539 adults with obesity (without diabetes) over 72 weeks: STEP 1: Semaglutide for Obesity The STEP 1 trial (NEJM, 2021) studied semaglutide 2.4mg in 1,961 adults with obesity (without diabetes) over 68 weeks: Cross-Trial Summary Comparing across trials (with the caveat that indirect comparison has limitations): tirzepatide 15mg produced about 6 percentage points more weight loss than semaglutide 2.4mg over similar timeframes

Cagrilintide (an amylin analog) combined with semaglutide as CagriSema is in late-stage trials for obesity

*All sales are FINAL, so please ensure you've selected the correct version before purchase